ACHV
NASDAQ · Biotechnology
Achieve Life Sciences Inc
$4.77
-0.52 (-9.83%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+568.6% upside
Low Target
$22.93
Average Target
$31.89
High Target
$41.27
Current Price
$4.77
Current
$4.77
$4.77
Target
$31.89
$31.89
$22.93
$31.89 avg
$41.27
Scenario Analysis
Bear Case
$22.93
380.7%
Low target
Base Case
$31.89
+568.6%
Avg target
Bull Case
$41.27
+765.2%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$6.15
-22.4% from high
52-Week Low
$2.00
+138.5% from low
Target vs 52W High
$31.89
+418.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +20.5% |
| AMGN | Hold | 44 | 48% | $190.87 | -42.2% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +178.4% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.1% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -88.0% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.2% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -23.9% |
| BIIB | Buy | 43 | 56% | $91.45 | -52.0% |